Nifty
Sensex
:
:
22482.25
74005.94
16.15 (0.07%)
88.91 (0.12%)

Pharmaceuticals & Drugs - API

Rating :
42/99

BSE: 524348 | NSE: AARTIDRUGS

487.80
18-May-2024
  • Open
  • High
  • Low
  • Previous Close
  •  492.75
  •  492.75
  •  486.60
  •  490.55
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  9093
  •  44.43
  •  645.75
  •  431.05

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 4,490.57
  • 26.20
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 5,043.56
  • 0.20%
  • 3.50

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 57.13%
  • 1.08%
  • 25.12%
  • FII
  • DII
  • Others
  • 2.56%
  • 5.16%
  • 8.95%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 9.90
  • 11.71
  • 8.02

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.67
  • 7.97
  • -6.81

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 9.65
  • 13.13
  • -15.98

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 19.81
  • 22.95
  • 23.46

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 4.01
  • 4.52
  • 4.41

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 12.37
  • 13.97
  • 15.05

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Jun 23
Jun 22
Var%
Net Sales
619.99
742.41
-16.49%
605.94
663.96
-8.74%
641.54
687.72
-6.71%
661.11
621.96
6.29%
Expenses
534.18
648.87
-17.68%
535.80
593.31
-9.69%
565.09
613.45
-7.88%
577.04
554.82
4.00%
EBITDA
85.81
93.54
-8.26%
70.14
70.65
-0.72%
76.45
74.27
2.94%
84.07
67.14
25.22%
EBIDTM
13.84%
12.60%
11.58%
10.64%
11.92%
10.80%
12.72%
10.79%
Other Income
1.08
0.87
24.14%
1.67
1.01
65.35%
0.68
0.06
1,033.33%
0.60
0.26
130.77%
Interest
9.13
8.63
5.79%
7.60
9.36
-18.80%
8.25
8.47
-2.60%
8.54
6.83
25.04%
Depreciation
13.58
12.50
8.64%
12.66
12.62
0.32%
12.61
12.66
-0.39%
12.60
12.54
0.48%
PBT
64.18
73.28
-12.42%
51.55
49.68
3.76%
56.27
53.20
5.77%
63.53
48.03
32.27%
Tax
16.87
17.10
-1.35%
14.84
13.01
14.07%
16.67
14.46
15.28%
15.56
13.25
17.43%
PAT
47.31
56.18
-15.79%
36.71
36.67
0.11%
39.60
38.74
2.22%
47.97
34.78
37.92%
PATM
7.63%
7.57%
6.06%
5.52%
6.17%
5.63%
7.26%
5.59%
EPS
5.15
6.06
-15.02%
3.99
3.96
0.76%
4.31
4.18
3.11%
5.17
3.76
37.50%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 11
Net Sales
2,528.58
2,716.05
2,488.65
2,154.78
1,806.09
1,560.94
1,243.63
1,195.17
1,139.84
1,096.88
501.05
Net Sales Growth
-6.90%
9.14%
15.49%
19.31%
15.71%
25.51%
4.05%
4.85%
3.92%
118.92%
 
Cost Of Goods Sold
1,677.72
1,813.56
1,614.49
1,263.35
1,127.29
1,013.53
737.72
744.43
735.08
724.24
321.34
Gross Profit
850.86
902.50
874.15
891.43
678.79
547.40
505.91
450.75
404.77
372.65
179.71
GP Margin
33.65%
33.23%
35.13%
41.37%
37.58%
35.07%
40.68%
37.71%
35.51%
33.97%
35.87%
Total Expenditure
2,212.11
2,406.60
2,156.05
1,714.40
1,540.57
1,350.03
1,041.76
1,004.68
960.02
924.51
431.87
Power & Fuel Cost
-
156.10
128.34
98.20
103.83
84.39
71.42
59.42
53.93
49.56
29.07
% Of Sales
-
5.75%
5.16%
4.56%
5.75%
5.41%
5.74%
4.97%
4.73%
4.52%
5.80%
Employee Cost
-
80.37
69.30
65.88
61.35
54.55
52.14
47.95
40.19
33.26
19.93
% Of Sales
-
2.96%
2.78%
3.06%
3.40%
3.49%
4.19%
4.01%
3.53%
3.03%
3.98%
Manufacturing Exp.
-
241.58
230.56
181.41
160.38
142.69
130.01
103.21
87.60
75.53
39.18
% Of Sales
-
8.89%
9.26%
8.42%
8.88%
9.14%
10.45%
8.64%
7.69%
6.89%
7.82%
General & Admin Exp.
-
28.31
30.42
29.03
21.39
14.24
12.22
12.81
10.98
10.48
4.86
% Of Sales
-
1.04%
1.22%
1.35%
1.18%
0.91%
0.98%
1.07%
0.96%
0.96%
0.97%
Selling & Distn. Exp.
-
76.01
73.99
70.99
59.46
37.51
34.00
31.16
27.82
28.99
16.21
% Of Sales
-
2.80%
2.97%
3.29%
3.29%
2.40%
2.73%
2.61%
2.44%
2.64%
3.24%
Miscellaneous Exp.
-
10.67
8.95
5.54
6.88
3.11
4.24
5.71
4.42
2.45
16.21
% Of Sales
-
0.39%
0.36%
0.26%
0.38%
0.20%
0.34%
0.48%
0.39%
0.22%
0.25%
EBITDA
316.47
309.45
332.60
440.38
265.52
210.91
201.87
190.49
179.82
172.37
69.18
EBITDA Margin
12.52%
11.39%
13.36%
20.44%
14.70%
13.51%
16.23%
15.94%
15.78%
15.71%
13.81%
Other Income
4.03
2.19
11.32
4.53
1.48
2.41
1.05
4.00
0.00
0.65
0.16
Interest
33.52
37.14
23.91
26.23
37.42
43.51
38.36
40.02
48.02
42.28
17.12
Depreciation
51.45
50.32
50.05
49.88
48.75
42.56
40.06
38.46
36.53
31.02
19.11
PBT
235.53
224.18
269.96
368.79
180.82
127.26
124.50
116.01
95.27
99.72
33.11
Tax
63.94
57.82
64.96
88.62
43.89
41.27
42.20
34.21
26.55
22.47
9.61
Tax Rate
27.15%
25.79%
24.06%
24.02%
23.69%
31.50%
33.90%
29.49%
27.87%
22.53%
29.02%
PAT
171.59
166.31
205.04
280.41
141.40
89.75
82.31
81.80
68.72
77.25
23.50
PAT before Minority Interest
171.48
166.36
205.00
280.40
141.40
89.75
82.31
81.80
68.72
77.25
23.50
Minority Interest
-0.11
-0.05
0.04
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
6.79%
6.12%
8.24%
13.01%
7.83%
5.75%
6.62%
6.84%
6.03%
7.04%
4.69%
PAT Growth
3.14%
-18.89%
-26.88%
98.31%
57.55%
9.04%
0.62%
19.03%
-11.04%
228.72%
 
EPS
18.67
18.10
22.31
30.51
15.39
9.77
8.96
8.90
7.48
8.41
2.56

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 11
Shareholder's Funds
1,192.43
1,036.36
913.42
652.49
543.45
455.43
400.13
357.40
308.15
163.16
Share Capital
92.60
92.60
93.20
23.30
23.58
23.58
23.86
24.22
24.22
12.11
Total Reserves
1,099.83
943.76
820.22
629.19
519.86
431.85
376.27
333.18
283.94
151.05
Non-Current Liabilities
295.75
231.60
257.25
300.82
321.06
312.31
296.59
243.78
211.03
290.20
Secured Loans
196.11
129.93
138.99
171.74
199.64
190.53
187.38
176.66
152.72
204.83
Unsecured Loans
8.57
8.57
8.57
8.57
8.57
12.17
14.17
14.57
10.75
62.65
Long Term Provisions
7.27
9.23
21.67
25.13
12.32
16.87
8.39
1.42
0.29
0.00
Current Liabilities
932.98
940.06
595.36
623.19
590.98
621.68
494.31
501.02
482.76
70.10
Trade Payables
480.27
468.67
329.97
329.55
242.63
258.73
196.97
184.90
166.72
65.30
Other Current Liabilities
87.80
111.33
105.38
132.83
82.94
56.42
51.00
43.80
41.53
1.77
Short Term Borrowings
360.55
356.34
157.21
157.73
263.25
305.64
244.66
258.41
252.43
0.00
Short Term Provisions
4.37
3.71
2.80
3.08
2.16
0.89
1.68
13.91
22.08
3.03
Total Liabilities
2,421.39
2,207.96
1,766.01
1,576.50
1,455.49
1,389.42
1,191.03
1,102.20
1,001.94
523.46
Net Block
676.23
689.93
665.40
643.81
624.86
602.39
581.09
493.42
448.46
247.84
Gross Block
1,204.97
1,169.00
1,101.02
1,030.97
970.09
909.20
848.13
725.47
685.21
393.33
Accumulated Depreciation
528.74
479.06
435.62
387.16
345.22
306.81
267.04
232.05
236.75
145.49
Non Current Assets
929.05
814.59
709.22
672.50
671.20
652.55
619.61
536.97
476.40
263.50
Capital Work in Progress
210.35
76.74
19.26
12.21
32.75
28.45
14.28
34.04
16.06
10.37
Non Current Investment
18.80
19.48
17.30
13.36
12.44
10.76
11.94
4.63
4.63
5.28
Long Term Loans & Adv.
23.67
28.44
7.26
3.12
1.15
10.95
12.30
4.88
7.24
0.00
Other Non Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
1,492.35
1,393.37
1,056.80
904.00
784.29
736.86
571.42
565.23
525.54
259.96
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
516.29
525.94
415.00
325.40
246.61
278.21
209.63
178.35
164.20
91.83
Sundry Debtors
864.84
749.90
555.23
488.63
458.54
374.94
296.81
331.69
314.27
121.34
Cash & Bank
8.96
22.33
9.78
7.64
5.55
4.27
4.17
4.82
3.58
5.27
Other Current Assets
102.26
0.70
2.44
6.82
73.58
79.44
60.81
50.37
43.49
41.52
Short Term Loans & Adv.
101.56
94.50
74.35
75.50
67.02
69.23
60.81
50.37
43.49
40.62
Net Current Assets
559.37
453.31
461.44
280.81
193.31
115.19
77.11
64.20
42.78
189.86
Total Assets
2,421.40
2,207.96
1,766.02
1,576.50
1,455.49
1,389.41
1,191.03
1,102.20
1,001.94
523.46

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 11
Cash From Operating Activity
134.20
70.41
154.95
250.74
143.09
69.77
174.75
133.29
104.59
20.56
PBT
224.18
269.96
369.01
185.29
131.02
124.50
116.01
95.27
99.72
33.11
Adjustment
85.15
71.19
68.60
86.84
75.20
75.12
71.63
79.30
69.40
38.76
Changes in Working Capital
-115.46
-187.35
-185.99
19.49
-33.49
-105.19
8.47
-21.25
-49.58
-40.22
Cash after chg. in Working capital
193.88
153.79
251.63
291.62
172.74
94.44
196.11
153.33
119.53
31.65
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-59.67
-83.38
-96.68
-40.88
-29.64
-24.67
-21.36
-20.03
-14.94
-11.09
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-163.97
-149.64
-71.78
-33.21
-61.67
-73.54
-106.98
-98.79
-107.01
-76.36
Net Fixed Assets
-132.85
-103.41
-70.18
-45.34
-62.81
-72.64
-92.88
-46.34
-322.27
-65.29
Net Investments
-0.59
-3.71
-3.94
-1.46
-1.68
1.18
-7.30
-0.01
13.50
-3.23
Others
-30.53
-42.52
2.34
13.59
2.82
-2.08
-6.80
-52.44
201.76
-7.84
Cash from Financing Activity
16.54
92.03
-81.13
-215.41
-80.07
3.92
-68.23
-33.26
1.46
52.55
Net Cash Inflow / Outflow
-13.23
12.80
2.04
2.13
1.35
0.15
-0.45
1.24
-0.95
-3.25
Opening Cash & Equivalents
21.61
8.81
6.77
4.64
3.29
3.15
3.60
3.58
4.53
8.52
Closing Cash & Equivalent
8.38
21.61
8.81
6.77
4.64
3.29
3.15
4.82
3.58
5.27

Financial Ratios

Consolidated /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 11
Book Value (Rs.)
128.77
111.92
98.01
70.01
57.61
48.28
41.93
36.90
31.81
16.84
ROA
7.19%
10.32%
16.78%
9.33%
6.31%
6.38%
7.13%
6.53%
10.13%
4.99%
ROE
14.93%
21.03%
35.81%
23.65%
17.97%
19.24%
21.60%
20.65%
32.78%
15.18%
ROCE
15.49%
20.75%
34.52%
21.39%
17.01%
17.31%
18.50%
18.33%
23.93%
13.12%
Fixed Asset Turnover
2.29
2.19
2.02
1.81
1.66
1.44
1.64
1.75
2.19
1.45
Receivable days
108.50
95.71
88.41
95.71
97.45
97.10
89.05
95.59
67.25
82.06
Inventory Days
70.03
69.00
62.71
57.80
61.36
70.52
54.97
50.69
39.52
54.05
Payable days
95.49
90.28
95.27
64.68
68.08
73.82
67.66
65.68
45.51
45.97
Cash Conversion Cycle
83.04
74.43
55.85
88.83
90.73
93.79
76.36
80.60
61.26
90.14
Total Debt/Equity
0.51
0.52
0.38
0.58
0.93
1.20
1.20
1.26
1.45
1.64
Interest Cover
7.04
12.29
15.07
5.95
4.01
4.25
3.90
2.98
3.36
2.93

News Update:


  • USFDA completes inspection at Baddi facility of Aarti Drugs’ arm
    23rd Apr 2024, 12:47 PM

    USFDA conducted inspection from April 16, 2024 to April 22, 2024

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.